Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126185671 | 12618567 | 1 | I | 20150403 | 20160726 | 20160803 | 20160803 | EXP | US-ASTRAZENECA-2016SE80728 | ASTRAZENECA | 23223.00 | DY | F | Y | 77.80000 | KG | 20160803 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126185671 | 12618567 | 1 | PS | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | U | 0 | ||||||||||
| 126185671 | 12618567 | 2 | SS | INDERAL | PROPRANOLOL HYDROCHLORIDE | 1 | Oral | U | U | 0 | 10 | MG | QD | ||||||
| 126185671 | 12618567 | 3 | SS | INDERAL | PROPRANOLOL HYDROCHLORIDE | 1 | Oral | U | U | 0 | 10 | MG | QD | ||||||
| 126185671 | 12618567 | 4 | SS | INDERAL | PROPRANOLOL HYDROCHLORIDE | 1 | Oral | 5 MG EVENING (PM) | U | U | 0 | ||||||||
| 126185671 | 12618567 | 5 | SS | RUXOLITINIB | RUXOLITINIB | 1 | Oral | U | 0 | ||||||||||
| 126185671 | 12618567 | 6 | SS | INCB018424 | RUXOLITINIB | 1 | Unknown | U | 0 | ||||||||||
| 126185671 | 12618567 | 7 | SS | LITHOBID | LITHIUM CARBONATE | 1 | Unknown | U | 0 | ||||||||||
| 126185671 | 12618567 | 8 | C | NEURONTIN | GABAPENTIN | 1 | 0 | ||||||||||||
| 126185671 | 12618567 | 9 | C | ANTIVERT | MECLIZINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 126185671 | 12618567 | 10 | C | NORCO | ACETAMINOPHENHYDROCODONE BITARTRATE | 1 | 0 | ||||||||||||
| 126185671 | 12618567 | 11 | C | VOLTAREN | DICLOFENAC SODIUM | 1 | 0 | ||||||||||||
| 126185671 | 12618567 | 12 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | 0 | ||||||||||||
| 126185671 | 12618567 | 13 | C | VESICARE | SOLIFENACIN SUCCINATE | 1 | 0 | ||||||||||||
| 126185671 | 12618567 | 14 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | 0 | ||||||||||||
| 126185671 | 12618567 | 15 | C | ASPIRIN. | ASPIRIN | 1 | 0 | ||||||||||||
| 126185671 | 12618567 | 16 | C | ATIVAN | LORAZEPAM | 1 | 0 | ||||||||||||
| 126185671 | 12618567 | 17 | C | CELEXA | CITALOPRAM HYDROBROMIDE | 1 | 0 | ||||||||||||
| 126185671 | 12618567 | 18 | C | PROTONIX | PANTOPRAZOLE SODIUM | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126185671 | 12618567 | 2 | Anxiety |
| 126185671 | 12618567 | 3 | Anxiety |
| 126185671 | 12618567 | 4 | Anxiety |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126185671 | 12618567 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126185671 | 12618567 | Hypotension | |
| 126185671 | 12618567 | Polycythaemia | |
| 126185671 | 12618567 | Sinus bradycardia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126185671 | 12618567 | 2 | 20131029 | 0 | ||
| 126185671 | 12618567 | 3 | 20150403 | 20150407 | 0 | |
| 126185671 | 12618567 | 4 | 20150403 | 20150407 | 0 |